ACCURAY INCARAYEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It is the developer of innovative technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, the latest generation TomoTherapy platform. The company is headquartered in Sunnyvale, CA, the United States. The platforms are installed in leading healthcare ...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 8.50% | 8.3M | — | 2024-01-25 |
| s/ | 5.66% | 5.5M | — | 2024-02-12 |
| The Vanguard Group | 5.43% | 5.3M | — | 2024-02-13 |
| NOS. OF ABOVE PERSONS | 0.80% | 796.9K | ▼ -5.91pp | 2024-09-06 |
Insider Transactions
Net 90d: +$134.7K · buys $134.7K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-28 | Leonel Peralta | SVP, Chief Operations Officer | Option exercise | 83.7K | $0.00 | $0 |
| 2026-02-20 | MAYER STEVEN F | Director | Buy (open market) | 54.9K | $0.56 | $30.9K |
| 2026-02-19 | MAYER STEVEN F | Director | Buy (open market) | 69.0K | $0.53 | $36.6K |
| 2026-02-18 | MAYER STEVEN F | Director | Buy (open market) | 126.1K | $0.53 | $67.2K |
1–4 of 4